 Flagship Pioneering today announced the unveiling of Tessera Therapeutics, Inc. a new company with the mission of curing disease by writing in the code of life. Tessera is pioneering Gene WritingTM, a new biotechnology that writes therapeutic messages into the genome to treat diseases at their source. 